descriptive
Analysis v1
Strong Support
A drug that activates GLP-1 receptors makes certain brain cells in mice more active — specifically ones that control appetite and reward.
6
0
Evidence from Studies
Supporting (1)
6
Community contributions welcome
6
GLP-1 and nicotine combination therapy engages hypothalamic and mesolimbic pathways to reverse obesity
Cohort Study
Animal
2023 May 30The study found that a drug activating GLP-1 receptors makes specific brain cells more active — those that help control appetite and reward — exactly as the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found